Abstract
Cabozantinib is an inhibitor of multiple receptor tyrosine kinases (RTKs) with roles in cancer pathogenesis. This review focuses on data relevant to t......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
